1. American Society of Reproductive Medicine and The Society for Reproductive Endocrinology and Fertility. Directory of Fellowship Programs in Reproductive Endocrinology and Infertility Available in 2017, 2016. www.socrei.org/uploadedFiles/Affiliates/SOCREI/Fellowships/REIFellowshipPrograms.pdf
2. The cost and consequences of assisted reproductive technology: an economic perspective. Hum Reprod Update
2010; 16(6): 603–613., ,
3. Centers for Disease Control and Prevention. Assisted reproductive technology 2012 national summary report. www.cdc.gov/art/ART2012
4. Survey of reasons for discontinuation from in vitro fertilization among couples attending infertility clinic. J Hum Reprod Sci
2014; 7(4): 249–254., , , ,
5. Why we should talk about compliance with assisted reproductive technologies (ART): a systematic review and meta-analysis of ART compliance rates. Hum Reprod Update
2013 Mar; 19(2): 124–135., , ,
6. The Practice Committee of the American Society for Reproductive Medicine and the Practice Committee of the Society for Assisted Reproductive Technology. Criteria for the number of embryos to transfer: a committee opinion, Fertil Steril
2013; 99: 44–46.
7. The frequency of uterine leiomyomas. Am J Clin Pathol
1990; 94: 435.,
8. The burden of uterine fibroids in five European countries, Eur J Obstet Gynecol Reprod Biol
2010; 152: 96., , et al.
9. Myomas and Reproductive Function, Practice Committee of American Society of Reproductive Medicine in collaboration with the Society of Reproductive Surgeons. Fertil Steril
2008; 90: s125–130.
10. FDA warns against using laparoscopic power morcellators to treat uterine fibroids. November 24, 2014. www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm424435.htm
11. FDA allows marketing of first-of-kind tissue containment system for use with certain laparoscopic power morcellators in select patients. April 7, 2016. www.fda.gov/NewsEvents/NewsRoom/PressAnouncement/ucm494650.htm
12. Inequities in the use of cesarean section deliveries in the world, Am J Obstet Gynecol
2012; 206: e1–19., , , , ,
13. Why do niches develop in Cesarean scars? Hypotheses on the aetiology of niche development. Hum Reprod
2015; 30(12): 2695–2702., , , ,
14. Laparoscopic repair of uteroperitoneal fistula. J S Laparoendsc Surg
2003; 7(4): 367–369., , , ,
15. Intrauterine adhesion prevention after hysteroscopy: a systematic review and meta-analysis, Am J Obstet Gynecol
2016; 267–275., , et al.
16. Prior uterine evacuation of pregnancy as independent risk factor for preterm birth: a systematic review and metaanalysis, Am J Obstet Gynecol
2016 May; 572–591., ,
17. Manual versus electric vacuum aspiration for early first-trimester abortion: a controlled study of complication rates, Obstet Gynecol
2004; 104: 101–107., , , ,
18. Three dimensional ultrasound in the diagnosis of Mullerian duct anomalies and concordance with magnetic resonance imaging, Ultrasound Obstet Gynecol
2010; 35: 593–601., , , , et al.
19. Septate uterus: new idea on the histologic features of the septum in this abnormal uterus. Am J Obstet Gynecol
1995; 172: 105–107., , , , , et al.
20. Practice Committee Opinion. Uterine septum: a guideline. Fertil Steril
2016; 106 (3): 530–539.
21. Mullerian duct anomalies: comparison of MRI diagnosis and clinical diagnosis, AJR Am J Roentgenol
2007; 189: 1294–1302., , , , , et al.
22. Hysteroscopically detected asymptomatic mullerian anomalies. Prevalence and reproductive implications, J Reprod Med
1995; 40: 684–688., , , , ,
23. Coexistence of endometriosis and uterine septum in patients with abortion or infertility. J Obstet Gynaecol Res
2011; 37: 1596–1600., , , , , et al.
24. Hysteroscopic metroplasty in patients with a uterine septum and otherwise unexplained infertility. Int J Gynaecol Obstet
2011; 113: 128–130., ,
25. A comparative study of the morphology of congenital uterine anomalies in women with and without a history of recurrent first trimester miscarriage. Hum Reprod
2003; 18: 162–166., , , ,
26. Repair of the uterine cavity after hysteroscopic septal incision, Fertil Steril
1990; 54: 991–994., , , , ,
27. What is the best time to perform intracytoplasmic sperm injection/embryo transfer cycle after hysteroscopic surgery for an incomplete uterine septum?
2008; 90: 2112–2115., , ,
28. Factors influencing the success of salpingostomy techniques for distal fimbrial obstruction, Obstet Gynecol
1978; 52: 591., , et al.
29. Surgical treatment for tubal disease in women due to undergo in vitro fertilization, Cochrane Database Syst Rev
2010 (1); CD002125., , , ,
30. Practice Committee of the American Society for Reproductive Medicine. Salpingectomy for hydrosalpinx prior to in vitro fertilization. Fertil Steril
2008; 90: s66–69.
31. 1997; 68(5): 887–891., Surgical management of cornual-isthmic tubal occlusion. Fertil Steril
32. The Practice Committee of the American Society for Reproductive Medicine. Role of tubal surgery in the era of assisted reproductive technology: a committee opinion, Fertil Steril
2015; 103(6): e37–e43.
33. The place of reconstructive tubal surgery in the era of ART. Reprod Biomed Online. 2015; 31: 722–731.
34. Predictors of success of reversal of sterilization, Fertil Steril
1995; 64: 29–36., ,
35. Laparoscopic tubal anastomosis: fertility outcome in 202 cases. Fertil Steril
1999; 72; 1121–1126., , , ,
36. Essure: summary of safety and effectiveness. www.fda.gov/ohrms/dockets/ac/02/briefing/3881b1_02.doc
37. Pregnancy success after hysteroscopic sterilization reversal, Obstet Gynecol
2014 Dec; 124(6): 1183–1189., ,
38. Essure multicenter off-label treatment for hydrosalpinx before in vitro fertilization. J Min Invasive Gynecol. 2011 May–Jun; 18(3): 338–342.,
39. Only hydrosalpinges visible on ultrasound are associated with reduced implantation and pregnancy rates after in vitro fertilization. Hum Reprod
1998; 13: 1696–1701., , , ,
40. Salpingectomy or proximal tubal occlusion of unilateral hydrosalpinx increases the potential for spontaneous pregnancy. Hum Reprod
2003; 18: 2634–2637., , , , , et al.
41. The changes in ovarian hormone levels and ovarian artery blood flow rate after laparoscopic tubal ligation, Eur J Obstet Gynecol Reprod Biol
2001; 99: 219–221., , , , ,
42. Tissue encapsulation of the proximal Essure mirco-insert from the uterine cavity following hysteroscopic sterilization. J Min Invas Gynecol
2007; 14: 202–204., , ,
43. 2013 (Joint Meeting of the 20th ISSTDR and 14th IUSTI Meeting); July 14–27, 2013; Vienna, Austria., , et al. Mycoplasma genitalium- is it a pathogen in acute pelvic inflammatory disease (PID)? STI & AIDS World Congress
44. Accuracy of five different diagnostic techniques in mild-to-moderate pelvic inflammatory disease, Infect Dis Obstet Gynecol
2002; 10: 171–180., , et al.
45. Pelvic Inflammatory Disease (PID). www.cdc.gov/std/tg2015/pid.htm
46. Clinical predictors of endometritis in women with symptoms and signs of pelvic inflammatory disease, Am J Obstet Gynecol
2001; 184: 856–864., , et al.
47. Treatment of acute pelvic inflammatory disease. Infect Dis Obstet Gynecol
48. Cost-effectiveness of alternative outpatient pelvic inflammatory disease treatment strategies, Sex Transm Dis
2007; 34: 960–966., , et al.
49. Surgical considerations in the diagnosis and treatment of pelvic inflammatory disease. Surg Clin North Am
1991; 71(5): 947–962.
50. Tubo-ovarian abscess: a retrospective review, Am J Ob stet Gynecol
1980; 138: 1055., , et al.
51. Surgical indications and treatment of acute pelvic inflammatory disease, Am J Surg
1962; 104(4): 555–559., ,
52. Adhesion formation and reproductive outcome after myomectomy and second-look laparoscopy. Obstet Gynecol
1993; 82: 213–215., ,
53. Anterior abdominal wall adhesions after laparotomy or laparoscopy. J Am Assoc Gynecol Laparosc
1997; 4: 353–356., ,
54. Antibiotic irrigation and the formation of intraabdominal adhesions. Am J Surg
1989; 44: 115–136., , ,
55. The rates of adhesion development and the effects of crystalloid solutions on the adhesion development in pelvic surgery. Fertil Steril
1998; 70: 702–711., ,
56. Prevention of de novo adhesion formation after laparoscopic myomectomy: a randomized trial to evaluate the effectiveness of an oxidized regenerated cellulose absorbable barrier, Hum Reprod
1995; 10: 3133–3135., , , , ,
57. Pathogenesis, consequences, and control of peritoneal adhesions in gynecologic surgeons. Practice Committee of the American Society for Reproductive Medicine. Reproductive Surgeons Fertil Steril
2007; 88: 21–26.